This is a sleep problem where you stop breathing for short periods during sleep. It happens because your brain doesn't send the right signals to your muscles to breathe. This is different from the more common type where your airway gets blocked.
Every report comes from a Lived member, sent anonymously.
Have you tried CPAP for Central Sleep Apnea?
Central sleep apnea is a sleep disorder in which breathing repeatedly stops or becomes very shallow because the brain briefly stops sending the signal to breathe. During each pause, the chest and belly muscles make no effort at all. That is the key difference from obstructive sleep apnea, the far more common type, in which the throat collapses while the body keeps trying to breathe. The pauses last at least 10 seconds and can happen many times an hour. Each one tends to end with a brief awakening, so sleep becomes fragmented even when a person doesn't remember waking. People may feel tired or low on energy during the day, sleep poorly, wake up short of breath, or have a bed partner notice that their breathing stops. Daytime sleepiness is often milder than in obstructive sleep apnea, which can make the condition easy to miss. Central sleep apnea is less a single disease than a breathing pattern with several possible causes, and the cause largely shapes treatment. In people with heart failure it often takes the form of Cheyne-Stokes breathing, a repeating cycle in which breaths grow deeper, then fade away into a pause. This page focuses on adults. Rare inherited conditions such as congenital central hypoventilation syndrome (also called Ondine syndrome), and breathing pauses in premature babies, are managed by pediatric specialists.
Breathing during sleep is controlled automatically by the brainstem, which responds mainly to the level of carbon dioxide in the blood. Central sleep apnea develops when that control becomes unstable or suppressed. In some situations the system overreacts: breathing overshoots, carbon dioxide drops too low, and the brain pauses breathing until it rises again. In others, the brain's drive to breathe is dampened. The most common causes are heart failure (particularly when the heart's pumping is weakened), long-term use of opioid medicines such as methadone, stroke and other conditions that affect the brainstem, and sleeping at high altitude. Atrial fibrillation, kidney failure and some nerve and muscle diseases, such as amyotrophic lateral sclerosis and myasthenia gravis, are also linked to it. A form called treatment-emergent central sleep apnea can appear when someone starts CPAP (continuous positive airway pressure, a mask that delivers steady air pressure during sleep) for obstructive sleep apnea. When no cause can be found, it is called primary central sleep apnea, which is rare. The condition is more common in men and in older adults, and alcohol can also affect how the brain controls breathing during sleep. Having one of these risk factors does not mean someone will develop central sleep apnea, but it is a reason to take symptoms like unrefreshing sleep seriously.
Diagnosis starts with a conversation about sleep and daytime symptoms, heart and neurological health, current medicines (especially opioids) and any recent travel to high altitude. Observations from a bed partner can be very useful. The condition is confirmed with a sleep study. The most complete version, polysomnography, is done overnight in a sleep lab and records brain waves, airflow, oxygen levels, heart rhythm and the movement of the chest and abdomen. Those chest and belly sensors are what distinguish central from obstructive apnea: in a central pause, airflow stops and so does any effort to breathe. Simpler home tests can detect pauses but cannot measure sleep stages, so a lab study may be recommended when central apnea is suspected. Results are reported as breathing events per hour of sleep. Healthy people can have a few brief central pauses while drifting off. Five or more central apneas or hypopneas (partial pauses) per hour, making up most of the breathing events recorded, points to central sleep apnea. Because the cause matters so much, the evaluation may also include a heart ultrasound (echocardiogram), blood tests or brain imaging.
Treatment has two aims: address whatever is driving the central apnea, and improve sleep and how someone feels during the day. Sleep medicine guidelines stress that the goal is better symptoms and quality of life, not simply a lower number on the sleep study. Treating the cause often comes first. For heart failure, that means optimizing heart medicines and other heart failure care. For opioid-related apnea, the prescriber may review whether the dose can be lowered, and any change is planned together rather than made alone. At altitude, the problem usually eases within days as the body adjusts, or after returning to a lower elevation. Treatment-emergent apnea from CPAP often settles over several weeks of continued use. When symptoms persist, breathing machines worn with a mask during sleep are the main option. CPAP helps some people, partly by steadying the breathing pattern. A bilevel device with a backup rate goes further by delivering a breath when one doesn't start on its own. Adaptive servo-ventilation (ASV) is a more advanced machine that tracks breathing breath by breath and adds support during pauses. One important caveat: in people whose heart failure involves a weakened pumping heart (reduced ejection fraction), a large trial found higher death rates with ASV, so in that group it is used only at experienced centers with close follow-up. Other options include low-flow oxygen at night, mainly for apnea linked to heart failure or altitude, and acetazolamide, a prescription medicine that makes the blood slightly more acidic, which stimulates breathing. For selected adults with moderate to severe central sleep apnea, an implanted device can stimulate the phrenic nerve, which controls the diaphragm, to keep breathing steady during sleep. Because it requires a procedure, is costly and is not widely available, it is usually considered after other treatments. The research behind all of these options is limited, and guideline recommendations rest on low or very low certainty evidence. Finding the right approach can take some trial and adjustment.
The outlook depends heavily on the cause. Altitude-related central apnea is usually temporary, and treatment-emergent apnea often fades with time. When the cause is heart failure, a neurological condition or long-term medication, central sleep apnea tends to be ongoing and follows the course of that underlying condition. Living with a breathing machine takes some adjustment. Masks may need refitting, and dry mouth, congestion or nosebleeds are common complaints that different settings, a humidifier or another mask can often ease. The machines record how often they are used and how breathing responds, and the care team reviews that data to judge whether treatment is working. A repeat sleep study may be needed when treatment changes or symptoms return. Two practical points matter day to day. Sleepiness from untreated sleep apnea can slow reactions and judgment, so avoid driving when you feel drowsy. And because anesthesia and pain medicines can further suppress breathing, tell any surgical or procedure team that you have central sleep apnea.
Arrange an appointment if a bed partner notices pauses in your breathing, or if you have ongoing daytime tiredness, unrefreshing sleep, frequent awakenings or waking up short of breath, especially if you have heart failure, have had a stroke, take opioids long-term or recently started CPAP. Contact your care team if symptoms continue or come back despite treatment, if you can't tolerate your device, or if your medicines change, including a new or higher opioid dose.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Central Sleep Apnea is like, what's helped you, or ask the community a question.